<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163945.ref017">
 <label>17</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Jacobson</surname>
   <given-names>IM</given-names>
  </name>, 
  <name>
   <surname>McHutchison</surname>
   <given-names>JG</given-names>
  </name>, 
  <name>
   <surname>Dusheiko</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Di Bisceglie</surname>
   <given-names>AM</given-names>
  </name>, 
  <name>
   <surname>Reddy</surname>
   <given-names>KR</given-names>
  </name>, 
  <name>
   <surname>Bzowej</surname>
   <given-names>NH</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Telaprevir for previously untreated chronic hepatitis C virus infection</article-title>. 
  <source>The New England journal of medicine</source>. 
  <year>2011</year>;
  <volume>364</volume>(
  <issue>25</issue>):
  <fpage>2405</fpage>â€“
  <lpage>16</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1012912</pub-id> .
  <?supplied-pmid 21696307?>
  <pub-id pub-id-type="pmid">21696307</pub-id>
 </mixed-citation>
</ref>
